Richard J. Daly - 04 Jun 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
President and CEO, Director
Signature
/s/ Richard J. Daly
Issuer symbol
CPRX
Transactions as of
04 Jun 2024
Net transactions value
-$116,335
Form type
4
Filing time
05 Jun 2024, 17:00:50 UTC
Previous filing
16 Feb 2024
Next filing
25 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $160,400 +40,000 +19% $4.01* 252,147 04 Jun 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $276,735 -17,323 -6.9% $15.98 234,824 04 Jun 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -40,000 -2.3% $0.000000 1,731,012 04 Jun 2024 Common Stock 40,000 $4.01 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market in order to fund the exercise price and tax withholding of the exercise of the stock option.
F2 Derivative securities vested in three annual tranches beginning on January 2, 2019.